Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, has filed a new patent application. The nonprovisional application is a direct result of CBGL’s Project Varin and expands on the technologies and developments contained in the company’s provisional applications filed on Nov. 4, 2019. This recent application outlines new methods for the manufacture of highly bioavailable and ultra-fast-acting cannabinoids for use in a variety of applications, including in beverages, food and topicals. Calling the technology “revolutionary,” the announcement notes that this patent may rewrite the efficacy and cost equations in the cannabis industry; the technology also provides for considerably faster onset of active cannabinoids ingredients, with the potential to reduce the time from hours to minutes. “We believe what we have created is highly significant to the cannabis industry, especially as nationwide cannabis legalization looms on the horizon,” Cannabis Global CEO Arman Tabatabaei said in the press release. “This new cannabinoid delivery system is designed to allow beverage, food and cosmetic product formulators to use significantly less cannabinoids in products while achieving similar or meaningfully greater efficacy. Our patent filing covers not only the new processes developed to create the new forms of cannabinoids but also the nanoparticles and nanofibers using the outlined processes and ingredients. We are especially proud of the fact we have been able to use food-grade ingredients in many of the formulations allowing consumer product companies to produce the clean labels consumers are increasingly desiring.”
To view the full press release, visit https://ibn.fm/K0z46
About Cannabis Global Inc.
Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.
NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://ibn.fm/CBGL
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php
